Measurement of plasma fibronectin in patients who develop the adult respiratory distress syndrome

R. J. Maunder, J. M. Harlan, P. E. Pepe, S. Paskell, C. J. Carrico, L. D. Hudson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Depletion of plasma fibronectin has been observed in certain clinical conditions predisposing to the adult respiratory distress syndrome and has been associated with cardiopulmonary dysfunction in experimental lung injury. We evaluated prospectively the relationship between plasma fibronectin concentration and the development of the adult respiratory distress syndrome in patients known to be at high risk. Although plasma fibronectin levels in participants at study entry were lower in this population (mean 258 ± 132 μg/ml) than in normal volunteers (461 ± 127 μg/ml, p < 0.0025), there was no difference between patients who subsequently developed the adult distress syndrome (mean 255 ± 149 μg/ml) and those with similar illness or injury who did not develop the syndrome (260 ± 126 μg/ml). Fibronectin concentration was not further depressed even after development of adult respiratory distress syndrome and did not correlate with degree of pulmonary dysfunction. These data suggest that fibronectin depletion is not an important determinant of respiratory failure in humans. Patients with sepsis syndrome had significantly lower plasma fibronectin levels than those without sepsis (187 ± 119 μg/ml vs. 273 ± 131 μg/ml, p < 0.05), suggesting a possible role for fibronectin in the pathogenesis of sepsis.

Original languageEnglish (US)
Pages (from-to)583-590
Number of pages8
JournalJournal of Laboratory and Clinical Medicine
Volume104
Issue number4
StatePublished - 1984

Fingerprint

Adult Respiratory Distress Syndrome
Fibronectins
Plasmas
Sepsis
Systemic Inflammatory Response Syndrome
Lung Injury
Respiratory Insufficiency
Healthy Volunteers
Lung
Wounds and Injuries
Population

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Maunder, R. J., Harlan, J. M., Pepe, P. E., Paskell, S., Carrico, C. J., & Hudson, L. D. (1984). Measurement of plasma fibronectin in patients who develop the adult respiratory distress syndrome. Journal of Laboratory and Clinical Medicine, 104(4), 583-590.

Measurement of plasma fibronectin in patients who develop the adult respiratory distress syndrome. / Maunder, R. J.; Harlan, J. M.; Pepe, P. E.; Paskell, S.; Carrico, C. J.; Hudson, L. D.

In: Journal of Laboratory and Clinical Medicine, Vol. 104, No. 4, 1984, p. 583-590.

Research output: Contribution to journalArticle

Maunder, RJ, Harlan, JM, Pepe, PE, Paskell, S, Carrico, CJ & Hudson, LD 1984, 'Measurement of plasma fibronectin in patients who develop the adult respiratory distress syndrome', Journal of Laboratory and Clinical Medicine, vol. 104, no. 4, pp. 583-590.
Maunder, R. J. ; Harlan, J. M. ; Pepe, P. E. ; Paskell, S. ; Carrico, C. J. ; Hudson, L. D. / Measurement of plasma fibronectin in patients who develop the adult respiratory distress syndrome. In: Journal of Laboratory and Clinical Medicine. 1984 ; Vol. 104, No. 4. pp. 583-590.
@article{17858d0d24ad4f299c3690ff5c8580ef,
title = "Measurement of plasma fibronectin in patients who develop the adult respiratory distress syndrome",
abstract = "Depletion of plasma fibronectin has been observed in certain clinical conditions predisposing to the adult respiratory distress syndrome and has been associated with cardiopulmonary dysfunction in experimental lung injury. We evaluated prospectively the relationship between plasma fibronectin concentration and the development of the adult respiratory distress syndrome in patients known to be at high risk. Although plasma fibronectin levels in participants at study entry were lower in this population (mean 258 ± 132 μg/ml) than in normal volunteers (461 ± 127 μg/ml, p < 0.0025), there was no difference between patients who subsequently developed the adult distress syndrome (mean 255 ± 149 μg/ml) and those with similar illness or injury who did not develop the syndrome (260 ± 126 μg/ml). Fibronectin concentration was not further depressed even after development of adult respiratory distress syndrome and did not correlate with degree of pulmonary dysfunction. These data suggest that fibronectin depletion is not an important determinant of respiratory failure in humans. Patients with sepsis syndrome had significantly lower plasma fibronectin levels than those without sepsis (187 ± 119 μg/ml vs. 273 ± 131 μg/ml, p < 0.05), suggesting a possible role for fibronectin in the pathogenesis of sepsis.",
author = "Maunder, {R. J.} and Harlan, {J. M.} and Pepe, {P. E.} and S. Paskell and Carrico, {C. J.} and Hudson, {L. D.}",
year = "1984",
language = "English (US)",
volume = "104",
pages = "583--590",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Measurement of plasma fibronectin in patients who develop the adult respiratory distress syndrome

AU - Maunder, R. J.

AU - Harlan, J. M.

AU - Pepe, P. E.

AU - Paskell, S.

AU - Carrico, C. J.

AU - Hudson, L. D.

PY - 1984

Y1 - 1984

N2 - Depletion of plasma fibronectin has been observed in certain clinical conditions predisposing to the adult respiratory distress syndrome and has been associated with cardiopulmonary dysfunction in experimental lung injury. We evaluated prospectively the relationship between plasma fibronectin concentration and the development of the adult respiratory distress syndrome in patients known to be at high risk. Although plasma fibronectin levels in participants at study entry were lower in this population (mean 258 ± 132 μg/ml) than in normal volunteers (461 ± 127 μg/ml, p < 0.0025), there was no difference between patients who subsequently developed the adult distress syndrome (mean 255 ± 149 μg/ml) and those with similar illness or injury who did not develop the syndrome (260 ± 126 μg/ml). Fibronectin concentration was not further depressed even after development of adult respiratory distress syndrome and did not correlate with degree of pulmonary dysfunction. These data suggest that fibronectin depletion is not an important determinant of respiratory failure in humans. Patients with sepsis syndrome had significantly lower plasma fibronectin levels than those without sepsis (187 ± 119 μg/ml vs. 273 ± 131 μg/ml, p < 0.05), suggesting a possible role for fibronectin in the pathogenesis of sepsis.

AB - Depletion of plasma fibronectin has been observed in certain clinical conditions predisposing to the adult respiratory distress syndrome and has been associated with cardiopulmonary dysfunction in experimental lung injury. We evaluated prospectively the relationship between plasma fibronectin concentration and the development of the adult respiratory distress syndrome in patients known to be at high risk. Although plasma fibronectin levels in participants at study entry were lower in this population (mean 258 ± 132 μg/ml) than in normal volunteers (461 ± 127 μg/ml, p < 0.0025), there was no difference between patients who subsequently developed the adult distress syndrome (mean 255 ± 149 μg/ml) and those with similar illness or injury who did not develop the syndrome (260 ± 126 μg/ml). Fibronectin concentration was not further depressed even after development of adult respiratory distress syndrome and did not correlate with degree of pulmonary dysfunction. These data suggest that fibronectin depletion is not an important determinant of respiratory failure in humans. Patients with sepsis syndrome had significantly lower plasma fibronectin levels than those without sepsis (187 ± 119 μg/ml vs. 273 ± 131 μg/ml, p < 0.05), suggesting a possible role for fibronectin in the pathogenesis of sepsis.

UR - http://www.scopus.com/inward/record.url?scp=0021212046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021212046&partnerID=8YFLogxK

M3 - Article

C2 - 6481218

AN - SCOPUS:0021212046

VL - 104

SP - 583

EP - 590

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 4

ER -